Income from Continuous Operations: A company's total income or loss before discontinued operations, extraordinary items, preferred stock dividends and accounting change.
Lantern Pharma Inc. (LTRN) had Income from Continuous Operations of $-17.12M for the most recently reported fiscal year, ending 2025-12-31.
| Income Statement Financials | |
-- |
|
$-17.12M |
|
-- |
|
-- |
|
$17.98M |
|
$-17.98M |
|
$0.86M |
|
$-17.12M |
|
$-17.12M |
|
$-17.12M |
|
|
Income from Continuous Operations |
$-17.12M |
$-17.12M |
|
$-17.12M |
|
$-17.98M |
|
$-18.16M |
|
10.90M |
|
10.90M |
|
$-1.57 |
|
$-1.57 |
|
| Balance Sheet Financials | |
$10.80M |
|
$0.03M |
|
$0.23M |
|
$11.04M |
|
$4.50M |
|
-- |
|
-- |
|
$4.50M |
|
$6.53M |
|
$6.53M |
|
$6.53M |
|
11.26M |
|
| Cash Flow Statement Financials | |
$-15.68M |
|
$11.06M |
|
$1.50M |
|
$7.51M |
|
$4.42M |
|
$-3.09M |
|
$0.65M |
|
-- |
|
-- |
|
| Fundamental Metrics & Ratios | |
2.40 |
|
-- |
|
-- |
|
-- |
|
-- |
|
-- |
|
-- |
|
-- |
|
-- |
|
-- |
|
-- |
|
$-15.68M |
|
-- |
|
-- |
|
-- |
|
-- |
|
-- |
|
-- |
|
-- |
|
-262.00% |
|
-262.00% |
|
-155.13% |
|
-262.00% |
|
$0.58 |
|
$-1.44 |
|
$-1.44 |
|